{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-121463","form_type":"8-K","ticker":null,"cik":"0001017491","company_name":"SEELOS THERAPEUTICS, INC.","filed_at":"2023-11-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.883753+00:00","generated_at":"2026-06-07T20:44:43.055515+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Seelos Therapeutics 1-for-30 reverse split; authorized shares cut to 16M","bullets":["1-for-30 reverse stock split effective Nov 28, 2023; fractional shares rounded up.","Authorized common shares reduced from 480M to 16M.","Reverse split intended to regain Nasdaq $1.00 minimum bid compliance.","Trading symbol remains 'SEEL'; new CUSIP 81577F208.","Proportionate adjustments to warrants, options, and equity plan exercise prices."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-121463","json":"https://secwatch.observer/filing/0001104659-23-121463.json","markdown":"https://secwatch.observer/filing/0001104659-23-121463.md","text":"https://secwatch.observer/filing/0001104659-23-121463.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1017491/000110465923121463/0001104659-23-121463-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1017491/000110465923121463/tm2331470d3_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T20:44:43.055515+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"43e2fcb20c2f24a94dfab740efcf926c6179e104","claim":"SEELOS THERAPEUTICS, INC.: Filed a Certificate of Change with Nevada Secretary of State to effect a 1-for-30 reverse stock split and decrease authorized common shares from 480,000,000 to 16,000,000 (effective 2023-11-28).","evidence_excerpt":"On November 27, 2023, Seelos Therapeutics, Inc. (the “Company”) filed a Certificate of Change (the “Certificate of Change”) with the Secretary of State of the State of Nevada to (i) effect a 1-for-30 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”), and (ii) decrease the number of total authorized shares of Common Stock from 480,000,000 shares to 16,000,000 shares.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1017491/000110465923121463/0001104659-23-121463-index.htm","confidence":0.95,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-11-28"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}